Structural Heart Devices Global Market - Forecast to 2024

  • ID: 4600997
  • Report
  • Region: Global
  • 336 pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 5
Structural Heart Device Market is Expected to Grow at a Medium Double Digit CAGR to Reach $15,671.0 Million by 2024

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardiokinetix, Inc.
  • Cryo life, Inc.
  • JenaValve Technology GmbH
  • MiCardia Corporation
  • Occlutech
  • MORE

Structural heart devices has emerged as a new focus area of medical device manufacturers as the population of most developed and developing countries continue to become older and risk of cardiovascular diseases increase with aging. The cardiovascular diseases which also include structural heart diseases have become leading cause of death. It is projected that, with newfound prosperity due to globalization and industrialization has led to changing lifestyle leading to increasing risk of younger people developing cardiovascular diseases. The increased interest has led to development of new technologies and devices that are less invasive and address the need of treatment of patients who are considered too weak to withstand the trauma of an open heart surgery.

According to the publisher, Structural heart device market is expected to grow at a medium double digit CAGR to reach $15,671.0 million by 2024. The structural heart device market is classified based on product, product type and geography. The Structural heart devices market in this report is segmented by Product, Product type and Geography. Structural heart devices by product are segmented into Repair devices and Replacement devices. Repair devices by product type is segmented into Surgical Heart Repair (Annuloplasty) and Transcatheter heart repair devices. Transcatheter heart repair devices are further classified as Valvuloplasty, Occluders, Transcatheter Mitral Valve Repair and Others (Chordal replacement in mitral valve repair, Transcatheter tricuspid valve repair and Ventricular remodelling). Replacement devices by product type are segmented into Surgical Valve Replacement and Transcatheter Valve Replacement. Surgical valve replacement devices are further sub-segmented into Mechanical valves and Tissue valves. Transcatheter Valve Replacement devices are sub-segmented into Transcatheter aortic valve replacement (TAVR), Transcatheter Mitral valve replacement (TMVR), Transcatheter pulmonary valve replacement (TPVR).

The structural heart devices global market is segmented into repair and replacement devices based on the products. The replacement devices segment held the largest market revenue in 2017 and expected to grow at a medium double digit CAGR from 2017 to 2024. In structural heart repair devices segment, transcatheter repair device held the largest share in 2017 and is projected to grow at a strong double digit CAGR from 2017 to 2024. Among transcatheter repair devices, Transcatheter mitral valve repair device held the largest share in 2017 and is projected to grow at a strong double digit CAGR from 2017 to 2024. The Structural heart Replacement segment is dominated by Transcatheter valve replacement that held largest share in 2017 and expected to grow at a strong double digit CAGR from 2017 to 2024. Among the Surgical valve replacement devices, Tissue valves held the largest share in 2017 and is expected to grow at a single digit CAGR from 2017 to 2024. Among the Transcatheter valve replacement devices, Transcatheter Aortic Valve Replacement (TAVR) devices held the largest share and expected to grow at a medium double digit CAGR from 2017 to 2024 and Transcatheter Mitral Valve Replacement (TMVR) devices is expected to grow at a strong double digit CAGR from 2017 to 2024.

The structural heart devices market by geography is divided into North America (U.S., Others), Europe (Germany, Italy, France, Others), Asia-pacific (Japan, China, Korea, Others) and Rest of the World (Brazil, Rest of Latin America, Middle East and Others).

North America region held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024. Among North America countries, U.S. held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024. Europe held the second largest share and is expected to grow at a medium double digit CAGR from 2017 to 2024. Among European countries, Germany held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024. Asia-Pacific is expected to grow at a strong double digit CAGR from 2017 to 2024. Among APAC countries, Japan held the highest share in 2017 and is expected to grow at a strong double digit CAGR from 2017 to 2024. RoW is expected to grow at a medium double digit CAGR from 2017 to 2024. Among RoW countries, Brazil held the largest share in 2017 and is expected to grow at a medium double digit CAGR from 2017 to 2024.

Some of the major players in structural heart devices market include Abbott laboratories (U.S.), Medtronic (Ireland), Boston Scientific (U.S.), Edward Lifesciences (U.S.), LivaNova (U.K.), Lepu Medicals (China), JenaValve Technologies GmbH (Germany), Braile biomedia (Brazil), Cryolife (U.S.), Labcore Laboratories ltd (Brazil).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

North America

  • U.S.
  • Others

Europe

  • Germany
  • Italy
  • France
  • Others

Asia-Pacific

  • Japan
  • China
  • Korea
  • Others

Rest of the World (RoW)

  • Brazil
  • Rest of Latin America
  • Middle East & Other
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardiokinetix, Inc.
  • Cryo life, Inc.
  • JenaValve Technology GmbH
  • MiCardia Corporation
  • Occlutech
  • MORE

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Scope Of The Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown And Data Triangulation
2.6.3 Secondary Sources
2.6.4 Primary Sources
2.6.5 Key Data Points From Secondary Sources
2.6.6 Key Data Points From Primary Sources
2.6.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Increase In Minimally Invasive Surgery For Structural Heart Diseases
3.3.1.2 Technology Advancements And Growing Healthcare Budgetary Allocation
3.3.1.3 Rising Geriatric Population With Structural Heart Diseases
3.3.1.4 Acquisitions To Open An Array Of Opportunities For The Market To Flourish
3.3.1.5 Vast Pipeline Products
3.3.2 Restraints And Threats
3.3.2.1 High Cost Of The Structural Heart Devices
3.3.2.2 Lack Of Patient Awareness And Healthcare Infrastructure In Developing Countries
3.3.2.3 Stringent Regulatory Guidelines
3.3.2.4 Lack Of Skilled And Trained Professionals
3.4 Regulatory Affairs
3.4.1 International Organization For Standardization
3.4.1.1 Iso 9001: 2015 Quality Management System
3.4.1.2 Iso 13485 Medical Devices
3.4.1.3 Iso 10993 Biological Evaluation Of Medical Devices
3.4.2 U.S.
3.4.3 Canada
3.4.4 Europe
3.4.5 Japan
3.4.6 China
3.4.7 India
3.5 Reimbursement Scenario
3.5.1 Reimbursement Table
3.6 Patent Trends
3.7 Technological Advancements
3.7.1 Introduction
3.7.2 Tissue Engineering
3.7.3 Polymeric Heart Valves
3.7.4 Sutureless Aortic Valve Replacement (SU-AVR) System
3.7.5 Endoscopic Aortic Valve Replacement (TEVAR) System
3.7.6 3-D Printed Model
3.8 Clinical Trials
3.9 Porter’S Five Force Analysis
3.9.1 Threat Of New Entrants
3.9.2 Threat Of Substitutes
3.9.3 Bargaining Power Of Suppliers
3.9.4 Bargaining Power Of Buyers
3.9.5 Competitive Rivalry
3.10 Supply Chain Analysis
3.11 Market Share Analysis By Major Players
3.11.1 Structural Heart Devices Global Market Share Analysis
3.11.2 Market Share Analysis Of Annuloplasty Repair Devices By Major Players
3.11.3 Market Share Analysis Of Occluders By Major Players
3.11.4 Market Share Analysis Of Mechanical Valve Replacement Devices By Major Players
3.11.5 Market Share Analysis Of Tissue Valve Replacement Devices By Major Players
3.11.6 Market Share Analysis Of Transcatheter Aortic Valve Replacement By Major Players
3.12 Structural Heart Diseases U.S. Market Penetration, Prevalence, Opportunity And Number Of Procedures Performed
3.13 Structural Heart Devices Number Of Units By Region
3.13.1 Occluders Number Of Units By Region
3.13.2 Transcatheter Mitral Valve Repair Devices Number Of Units By Region
3.13.3 Surgical Valve Repari - Annuloplasty Devices Number Of Units By Region
3.13.4 Transcatheter Aortic Valve Replacement (TAVR) Devices Number Of Units By Region
3.13.5 Transcatheter Mitral Valve Replacement (TMVR) Devices Number Of Units By Region
3.13.6 Transcatheter Pulmonary Valve Replacement (TPVR) Devices Number Of Units By Region
3.14 Structural Heart Devices Company Comparison Table By Products
3.14.1 Aortic Valve Devices Company Comparison Table By Products
3.14.2 Mitral Valve Devices Company Comparison Table By Products
3.14.3 Closure Devices (Occluders) Company Comparison Table By Products
3.14.4 Other Structural Heart Devices Company Comparison Table By Products

4 Structural Heart Devices Global Market, By Product
4.1 Introduction
4.2 Structural Heart Repair Devices
4.2.1 Surgical Heart Repair (Annuloplasty)
4.2.2 Transcatheter Heart Repair Devices
4.2.2.1 Valvuloplasty
4.2.2.2 Occluders
4.2.2.3 Transcatheter Mitral Valve Repair
4.2.2.4 Other Transcatheter Repair Devices
4.3 Structural Heart Valve Replacement Devices
4.3.1 Introduction
4.3.2 Surgical Valve Replacement Devices
4.3.2.1 Mechanical Heart Valves
4.3.2.2 Tissue Heart Valves (Biological Valves)
4.3.3 Transcatheter Valve Replacement Devices
4.3.3.1 Transcatheter Aortic Valve Replacement (TAVR)
4.3.3.2 Transcatheter Mitral Valve Replacement (TMVR)
4.3.3.3 Transcatheter Pulmonary Valve Replacement (TPVR)

5 Regional Analysis
5.1 Introduction
5.2 North America
5.2.1 U.S.
5.2.2 Others
5.3 Europe
5.3.1 Germany
5.3.2 Italy
5.3.3 France
5.3.4 Others
5.4 Apac
5.4.1 Japan
5.4.2 China
5.4.3 Korea
5.4.4 Others
5.5 Row
5.5.1 Brazil
5.5.2 Rest Of Latam
5.5.3 Middle East & Others

6 Competitive Landscape
6.1 Introduction
6.2 Approvals
6.3 Acquisitions
6.4 New Product Launch
6.5 Agreements
6.6 Other Developments

7 Major Companies
7.1 Abbott Laboratories
7.1.1 Overview
7.1.2 Financials
7.1.3 Product Portfolio
7.1.4 Key Developments
7.1.5 Business Strategy
7.1.6 Swot Analysis
7.2 Boston Scientific Corpoartion
7.2.1 Overview
7.2.2 Financials
7.2.3 Product Portfolio
7.2.4 Key Developments
7.2.5 Business Strategy
7.2.6 Swot Analysis
7.3 Braile Biomedica
7.3.1 Overview
7.3.2 Financials
7.3.3 Product Portfolio
7.3.4 Key Developments
7.3.5 Business Strategy
7.3.6 Swot Analysis
7.4 Cryolife, Inc.
7.4.1 Overview
7.4.2 Financials
7.4.3 Product Portfolio
7.4.4 Key Developments
7.4.5 Business Strategy
7.4.6 Swot Analysis
7.5 Edwards Lifesciences Corp.
7.5.1 Overview
7.5.2 Financials
7.5.3 Product Portfolio
7.5.4 Key Developments
7.5.5 Business Strategy
7.5.6 Swot Analysis
7.6 Jenavalve Technology
7.6.1 Overview
7.6.2 Financials
7.6.3 Product Portfolio
7.6.4 Key Developments
7.6.5 Business Strategy
7.6.6 Swot Analysis
7.7 Labcor Laboratorios Ltda.
7.7.1 Overview
7.7.2 Financials
7.7.3 Product Portfolio
7.7.4 Key Developments
7.7.5 Business Strategy
7.7.6 Swot Analysis
7.8 Lepu Medical Technology (Beijing) Co., Ltd.
7.8.1 Overview
7.8.2 Financials
7.8.3 Product Portfolio
7.8.4 Key Developments
7.8.5 Business Strategy
7.8.6 Swot Analysis
7.9 Livanova Plc (Sorin Group)
7.9.1 Overview
7.9.2 Financials
7.9.3 Product Portfolio
7.9.4 Key Developments
7.9.5 Business Strategy
7.9.6 Swot Analysis
7.10 Medtronic, Plc
7.10.1 Overview
7.10.2 Financials
7.10.3 Product Portfolio
7.10.4 Key Developments
7.10.5 Business Strategy
7.10.6 Swot Analysis

List Of Tables
Table 1 Structural Heart Devices Global Market Revenue, By Region,(2016-2024)($Mn)
Table 2 Occluders Number Of Units, By Region,(2016-2024)(No’s)
Table 3 Transcatheter Mitral Valve Repair Devices Number Of Units, By Region,(2016-2024)(No’s)
Table 4 Annuloplasty Devices Number Of Units, By Region, (2016-2024) (No’s)
Table 5 TAVR Devices Number Of Units, By Region,(2016-2024)(No’s)
Table 6 TMVR Devices Number Of Units, By Region,(2016-2024)(No’s)
Table 7 TPVR Devices Number Of Units,By Region,(2016-2024)(No’s)
Table 8 Structural Heart Devices Global Market Revenue, By Product,(2016-2024) ($Mn)
Table 9 Structural Heart Devices Global Market Revenue,By Region,(2016-2024) ($Mn)
Table 10 Structural Heart Repair Devices Global Market Revenue, By Product Type, (2016-2024)($Mn)
Table 11 Structural Heart Repair Devices Global Market Revenue, By Region, (2016-2024)($Mn)
Table 12 Structural Heart Repair (Annuloplasty) Global Market Revenue, By Region, (2016-2024)($Mn)
Table 13 Transcatheter Heart Repair Devices Global Market Revenue,  By Product Type, (2016-2024)($Mn)
Table 14 Transcatheter Heart Repair Devices Global Market Revenue,By Region, (2016-2024) ($Mn)
Table 15 Valvuloplasty Global Market Revenue, By Region, (2016-2024)($Mn)
Table 16 Occluders Global Market Revenue, By Region, (2016-2024) ($Mn)
Table 17 Transcatheter Mitral Valve Repair Global Market Revenue,By Region, (2016-2024) ($Mn)
Table 18 Other Transcatheter Repair Devices Global Market Revenue, By Region, (2016-2024) ($Mn)
Table 19 Structural Heart Valve Replacement Devices Global Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 20 Structural Heart Valve Replacement Devices Global Market Revenue, By Region,(2016-2024) ($Mn)
Table 21 Surgical Valve Replacement Devices Global Market Revenue, By Product Type,(2016-2024)($Mn)
Table 22 Surgical Valve Replacement Devices Global Market Revenue, By Region,(2016-2024) ($Mn)
Table 23 Mechanical Heart Valves Global Market Revenue, By Region,(2016-2024)($Mn)
Table 24 Tissue Heart Valves Global Market Revenue, By Region, (2016-2024) ($Mn)
Table 25 Transcatheter Valve Replacement Devices Global Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 26 Transcatheter Valve Replacement Devices Global Market Revenue, By Region, (2016-2024) ($Mn)
Table 27 Transcatheter Aortic Valve Replacement Global Market Revenue, By Region, (2016-2024) ($Mn)
Table 28 Transcatheter Mitral Valve Replacement Global Market Revenue, By Region, (2016-2024) ($Mn)
Table 29 Transcatheter Pulmonary Valve Replacement Global Market Revenue, By Region, (2016-2024) ($Mn)
Table 30 Structural Heart Devices Global Market Revenue, By Region,(2016-2024) ($Mn)
Table 31 North America Structural Heart Devices Market Revenue, By Product, (2016-2024) ($Mn)
Table 32 North America Structural Heart Repair Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 33 North America Transcatheter Heart Repair Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 34 North America Structural Heart Replacement Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 35 North America Surgical Valve Replacement Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 36 North America Transcatheter Valve Replacement Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 37 North America Structural Heart Devices Market Revenue,By Country, (2016-2024) ($Mn)
Table 38 North America TAVR Market Revenue, By Country,(2016-2024)($Mn)
Table 39 Europe Structural Heart Devices Market Revenue, By Product, (2016-2024) ($Mn)
Table 40 Europe Structural Heart Repair Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 41 Europe Transcatheter Heart Repair Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 42 Europe Structural Heart Replacement Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 43 Europe Surgical Valve Replacement Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 44 Europe Transcatheter Valve Replacement Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 45 Europe Structural Heart Devices Market Revenue,By Country, (2016-2024) ($Mn)
Table 46 Europe TAVR Market Revenue, By Country,(2016-2024) ($Mn)
Table 47 APAC Structural Heart Devices Market Revenue,By Product, (2016-2024) ($Mn)
Table 48 APAC Structural Heart Repair Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 49 APAC Transcatheter Heart Repair Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 50 APAC Structural Heart Replacement Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 51 APAC Surgical Valve Replacement Market Revenue,By Product Type, (2016-2024) ($Mn)
Table 52 APAC Transcatheter Valve Replacement Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 53 APAC Structural Heart Devices Market Revenue,By Country, (2016-2024) ($Mn)
Table 54 APAC TAVR Market Revenue, By Country, (2016-2024) ($Mn)
Table 55 RoW Structural Heart Devices Market Revenue,  By Product, (2016-2024) ($Mn)
Table 56 RoW Structur Heart Repair Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 57 RoW Transcatheter Heart Repair Devices Market Revenue,By Product Type, (2016-2024) ($Mn)
Table 58 RoW Structural Heart Replacement Devices Market Revenue, By Product Type, (2016-2024) ($Mn)
Table 59 RoW Surgical Valve Replacement Market Revenue,By Product Type, (2016-2024) ($Mn)
Table 60 RoW Transcatheter Valve Replacement Market Revenue,By Product Type, (2016-2024) ($Mn)
Table 61 RoW Structural Heart Devices Market Revenue, By Country, (2016-2024) ($Mn)
Table 62 RoW TAVR Market Revenue, By Country, (2016-2024) ($Mn)
Table 63 Approvals (2016 - 2018)
Table 64 Acquisitions (2016 - 2018)
Table 65 New Product Launch (2016 - 2018)
Table 66 Agreements (2016 - 2018)
Table 67 Other Developments (2016 - 2018)
Table 68 Abbott Laboratories: Total Revenue And R&D Expenses,(2015-2017) ($Mn)
Table 69 Abbott Laboratories: Total Revenue By Segments,(2015-2017) ($Mn)
Table 70 Abbott Laboratories: Total Revenue By Geography,(2015-2017) ($Mn)
Table 71 Boston Scientific Corporation: Total Revenue And R&D Expenses, (2015-2017) ($Mn)
Table 72 Boston Scientific Corporation: Total Revenue By Segments, (2015-2017) ($Mn)
Table 73 Boston Scientific Corporation: Cardiovascular, By Segmnets, (2015-2017) ($Mn)
Table 74 Boston Scientific Corporation: Total Revenue By Geography, (2015-2017) ($Mn)
Table 75 Cryolife, Inc.: Total Revenue And  R&D Expenses, (2015-2017) ($Mn)
Table 76 Cryolife, Inc.: Total Revenue, By Segments, (2015-2017) ($Mn)
Table 77 Cryolife, Inc.: Total Revenue, By Products, (2015-2017) ($Mn)
Table 78 Cryolife, Inc.: Total Revenue, By Geography, (2015-2017) ($Mn)
Table 79 Edwards Lifesciences Corp.: Total Revenue And R&D Expenses, (2015-2017) ($Mn)
Table 80 Edwards Lifesciences Corp.: Total Revenue, By Segments,  (2015-2017) ($Mn)
Table 81 Edwards Lifesciences Corp.: Total Revenue, By Geography  (2015-2017) ($Mn)
Table 82 Livanova Plc: Total Revenue And R&D Expenses (2015-2017) ($Mn)
Table 83 Livanova Plc: Total Revenue, By Segments, (2015-2017) ($Mn)
Table 84 Livanova Plc: Total Revenue, By Geography, (2015-2017) ($Mn)
Table 85 Medtronic, Plc: Total Revenue And  R&D Expenses,(2015-2017*) ($Mn)
Table 86 Medtronic, Plc: Total Revenue, By Segments, (2015-2017*) ($Mn)
Table 87 Medtronic, Plc: Cardiac & Vascular Total Revenue, By Sub-Segments, (2015-2017*) ($Mn)
Table 88 Medtronic, Plc: Total Revenue, By Geography,(2015-2017*) ($Mn)

List Of Figures
Figure 1 Structural Heart Devices Global Market Revenue,By Region (2016-2024)($Mn)
Figure 2 Research Methodology: Structural Heart Devices Global Market
Figure 3 Structural Heart Devices Global Market: Top-Down And Bottom-Up Approach
Figure 4 Structural Heart Devices Global Market: Forecasting Model
Figure 5 Structural Heart Devices  Global Market: Market Breakdown & Data Triangulation
Figure 6 Structural Heart Devices  Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 Structural Heart Devices Market: Patent Filing By Major Players (2014–2018)
Figure 9 Structural Heart Device Global Market: Porter’S Analysis
Figure 10 Structural Heart Devices  Global Market: Supply Chain Analysis
Figure 11 Structural Heart Devices Global Market Share Analysis,   By Key Players, 2017 (%)
Figure 12 Annuloplasty Repair Devices Global Market Share Analysis, By Key Players, 2017 (%)
Figure 13 Closure Devices Global Market Share Analysis,  By Key Players, 2017 (%)
Figure 14 Mechanical Valve Replacement Devices Global Market Share Analysis, By Key Players, 2017 (%)
Figure 15 Tissue Valve Replacement Devices Global Market Share Analysis, By Key Players, 2017 (%)
Figure 16 TAVR Devices Global Market Share Analysis, By Key Players,2017 (%)
Figure 17 Structural Heart Diseases U.S. Market Penetration, Opportunity V/S Number Of Procedures Peformed, (2017) (No’s)
Figure 18 Structural Heart Devices Global Market Share,  By Product (2017 V/S 2024) (%)
Figure 19 Structural Heart Devices Global Market Share,  By Region (2017 V/S 2024) (%)
Figure 20 Structural Heart Repair Devices Global Market Revenue, By Product Type (2017) ($Mn)
Figure 21 Structural Heart Repair Devices Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 22 Structural Heart Repair (Annuloplasty) Global Market Share,By Region, (2017 V/S 2024) (%)
Figure 23 Transcatheter Heart Repair Devices Global Market Share,By Product Type (2017 V/S 2024) (%)
Figure 24 Transcatheter Heart Repair Devices Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 25 Valvuloplasty Global Market Share, By Region,(2017 V/S 2024) (%)
Figure 26 Occluders Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 27 Transcatheter Mitral Valve Repair Global Market Share,  By Region, (2017 V/S 2024) (%)
Figure 28 Other Transcatheter Repair Devices Global Market Share,By Region, (2017 V/S 2024) (%)
Figure 29 Structural Heart Valve Replacement Devices Global Market Share, By Product Type, (2017 V/S 2024) (%)
Figure 30 Structural Heart Valve Replacement Devices Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 31 Surgical Valve Replacement Devices Global Market Share,  By Product Type, (2017 V/S 2024) (%)
Figure 32 Surgical Valve Replacement Devices Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 33 Tissue Heart Valves Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 34 Transcatheter Valve Replacement Devices Global Market Share, By Product Type, (2017 V/S 2024) (%)
Figure 35 Transcatheter Valve Replacement Devices Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 36 Transcatheter Aortic Valve Replacement Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 37 Transcatheter Mitral Valve Replacement Global Market Share,   By Region, (2017 V/S 2024) (%)
Figure 38 Transcatheter Pulmonary Valve Replacement Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 39 Structural Heart Devices Global Market Revenue,  By Region (2016-2024) ($Mn), Cagr (%)
Figure 40 North America Structural Heart Repair Market Share, By Product Type And Transcatheter Repair, By Product Type(2017 V/S 2024) (%)
Figure 41 North America Structural Heart Replacement Market Share, By Product Type, Surgical And Transcatheter Valve Replacement, By Product Type (2017 V/S 2024) (%)
Figure 42 North America Structural Heart Devices Revenue,By Country (2017 V/S 2024) (%)
Figure 43 U.S. Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type (2017 V/S 2024) ($Mn)
Figure 44 Other North America Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type (2017 V/S 2024) ($Mn)
Figure 45 Europe Structural Heart Repair Market Share,  By Product Type And Transcatheter Repair, By Product Type(2017 V/S 2024) (%)
Figure 46 Europe Structural Heart Replacement Market Share,  By Product Type, Surgical And Transcatheter Valve Replacement, By Product Type (2017 V/S 2024) (%)
Figure 47 Europe Structural Heart Devices Share,By Country (2017 V/S 2024) (%)
Figure 48 Germany Structural Heart Devices Market Revenue,By Product, Repair And Replacement, By Product Type(2017 V/S 2024) ($Mn)
Figure 49 Italy Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type (2017 V/S 2024) ($Mn)
Figure 50 France Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type (2017 V/S 2024) ($Mn)
Figure 51 Other Europe Structural Heart Devices Market Revenue,  By Product, Repair And Replacement, By Product Type(2017 V/S 2024) ($Mn)
Figure 52 APAC Structural Heart Repair Market Share, By Product Type And Transcatheter Repair, By Product Type (2017 V/S 2024) (%)
Figure 53 APAC Structural Heart Replacement Market Share, By Product Type, Surgical And Transcatheter Valve Replacement,By Product Type (2017 V/S 2024) (%)235
Figure 54 APAC Structural Heart Devices Share,  By Country (2017 V/S 2024) (%)
Figure 55 Japan Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type (2017 V/S 2024) ($Mn)
Figure 56 China Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type (2017 V/S 2024) ($Mn)
Figure 57 Korea Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type (2017 V/S 2024) ($Mn)
Figure 58 Other APAC Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type (2017 V/S 2024) ($Mn)
Figure 59 RoW Structural Heart Repair Market Share, By Product Type And Transcatheter Repair, By Product Type (2017 V/S 2024) (%)
Figure 60 RoW Structural Heart Replacement Market Share, By Product Type, Surgical And Transcatheter Valve Replacement,  By Product Type (2017 V/S 2024) (%)
Figure 61 RoW Structural Heart Devices Share,   By Country (2017 V/S 2024) (%)
Figure 62 Brazil Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type (2017 V/S 2024) ($Mn)
Figure 63 Rest Of LATAM Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type(2017 V/S 2024) ($Mn)
Figure 64 Middle East & Others Structural Heart Devices Market Revenue, By Product, Repair And Replacement, By Product Type(2017 V/S 2024) ($Mn)
Figure 65 Key Growth Strategies, (2016-2018)
Figure 66 SWOT: Abbott Laboratories
Figure 67 SWOT: Boston Scientific Corporation
Figure 68 SWOT: Braile Biomedica
Figure 69 SWOT: Cryolife, Inc
Figure 70 SWOT: Edwards Lifesciences
Figure 71 SWOT: Jenavalve Technology
Figure 72 SWOT: Labcor Laboratories Ltda
Figure 73 SWOT: Lepu Medical Technology Co., Ltd.
Figure 74 SWOT: Livanova, Plc
Figure 75 SWOT: Medtronic, Plc

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Laboratories
  • Atricure
  • Balton Sp. z o.o.
  • Bard Peripheral Vascular, Inc.
  • Biostable Science and Engineering
  • BioVentrix, Inc.
  • BOSTON Scientific
  • Braile bio medica
  • Cardiac Dimensions, Inc.
  • Cardiokinetix, Inc.
  • Cardiosolutions, Inc
  • Cephea valve technologies
  • Claret Medical
  • Colibri Heart Valve, LLC
  • Comed BV
  • Cook medicals LLC
  • Cryo life, Inc.
  • Edward Lifescieces
  • Effluent medical
  • Guided Delivery Systems, Inc.
  • Hancock Jaffe
  • Heart Leaflet Technologies
  • High Life medicals
  • InterValve, Inc.
  • JC Medicals
  • JenaValve Technology GmbH
  • Labcor Laboratórios Ltda.
  • Leman Cardiovascular
  • Lepu medical
  • LivaNova PLC
  • Mardil Medicals
  • Medtentia International Ltd Oy
  • Medtronic PLC
  • MiCardia Corporation
  • Micro Interventional Devices
  • Mitralign
  • MitrAssist
  • NaviGate Cardiac Structures Inc.
  • Neochord
  • Novostia SA
  • NuMED, Inc.
  • NVT Med AG
  • Occlutech
  • Osypka AG
  • Secant Medical
  • Strait access technologies Pvt Ltd
  • The Phoenix Cardiac device Pvt Ltd
  • Thubrikar Aortic Valve, Inc.
  • Toray Industries, Inc.
  • TransCardiac Therapeutics, LLC
  • Transcatheter Technologies GmbH
  • TTKChitra HeartValve
  • Valcare Medical
  • Venus Medtech (Hangzhou) Inc.
  • W. L. Gore and Associates
  • Xeltis
  • Xuzhou Yatai Scientific Co.,Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll